Bernardini, N., Skroza, N., Rossi, G., Mambrin, A., Tolino, E., Marraffa, F., . . . Potenza, C. (2022). Long term efficacy, safety and tolerability of Tildrakizumab in epileptic patient with psoriasis and eczema. PAGEPress Publications.
Chicago Style (17th ed.) CitationBernardini, Nicoletta, et al. Long Term Efficacy, Safety and Tolerability of Tildrakizumab in Epileptic Patient with Psoriasis and Eczema. PAGEPress Publications, 2022.
MLA (9th ed.) CitationBernardini, Nicoletta, et al. Long Term Efficacy, Safety and Tolerability of Tildrakizumab in Epileptic Patient with Psoriasis and Eczema. PAGEPress Publications, 2022.
Warning: These citations may not always be 100% accurate.